We are live on ! Find out more
NLVP

New Leaf Venture Partners Portfolio holdings

AUM $43M
1-Year Est. Return 25.55%
This Fund
S&P 500
This Quarter Est. Return
+24.69%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$214M
AUM Growth
-$1.68M
Cap. Flow
-$32.7M
Cap. Flow %
-15.29%
Top 10 Hldgs %
93.75%
Holding
17
New
1
Increased
2
Reduced
5
Closed
1

Top Buys

Rank Stock Value
1
OBSV
ObsEva SA Ordinary Shares
OBSV
+$6.4M
2
RSLS
ReShape Lifesciences Inc. Common Stock
RSLS
+$4.1M
3
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$1.18M

Top Sells

Rank Stock Value
1
IRTC icon
iRhythm Holdings
IRTC
+$19.6M
2
DMTX
Dimension Therapeutics, Inc
DMTX
+$12.4M
3
WVE icon
Wave Life Sciences
WVE
+$5.83M
4
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$4.27M
5
SAGE
Sage Therapeutics
SAGE
+$1.93M

Sector Composition

Rank Sector Weight
1 Healthcare 96.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCPH
1
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$93M 43.52%
4,104,140
– –
PDSB icon
2
PDS Biotechnology
PDSB
$38.4M
$22M 10.28%
117,243
– –
IRTC icon
3
iRhythm Holdings
IRTC
$3.59B
$18.4M 8.62%
328,741
-375,000
-53% -$19.6M
WVE icon
4
Wave Life Sciences
WVE
$1.12B
$16.1M 7.52%
458,259
-200,000
-30% -$5.83M
CRSP icon
5
CRISPR Therapeutics
CRSP
$4.61B
$11.9M 5.58%
507,730
-20,000
-4% -$380K
OXFD
6
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$11.9M 5.57%
852,497
– –
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$10.4M 4.88%
69,956
– –
OBSV
8
DELISTED
ObsEva SA Ordinary Shares
OBSV
$8.69M 4.06%
890,501
+630,200
+242% +$6.4M
SAGE
9
DELISTED
Sage Therapeutics
SAGE
$4.12M 1.93%
25,000
-19,872
-44% -$1.93M
RSLS
10
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$3.85M 1.8%
+1,239
New +$4.1M
MRNS
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3.47M 1.62%
106,250
+43,750
+70% +$1.18M
TRIL
12
DELISTED
Trillium Therapeutics Inc.
TRIL
$2.93M 1.37%
404,159
– –
AVEO
13
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.69M 1.26%
96,452
-137,615
-59% -$4.27M
ALDR
14
DELISTED
Alder Biopharmaceuticals
ALDR
$1.96M 0.92%
171,364
– –
DERM
15
DELISTED
Dermira, Inc.
DERM
$1.7M 0.79%
61,109
– –
OTIC
16
DELISTED
Otonomy, Inc.
OTIC
$610K 0.29%
109,825
– –
DMTX
17
DELISTED
Dimension Therapeutics, Inc
DMTX
– –
-2,059,283
Closed -$12.4M

Similar funds

BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
WCPI
Wynnchurch Capital Partners IV Rosemont, Illinois $44.8M AUM 11.91% 1-Year Est. Return
WAMC
Western Asset Management Company Pasadena, California $45.2M AUM 6.96% 1-Year Est. Return
CC
Corton Capital Carrying Place, Ontario, Canada $40.7M AUM 52.32% 1-Year Est. Return
CIEP
Constellation Investimentos e Participacoes Sao Paulo, Brazil $46.7M AUM 23.3% 1-Year Est. Return
IPI
Inflection Point Investments London, United Kingdom $46.9M AUM 18.35% 1-Year Est. Return
VSAM
Value Star Asset Management Hong Kong $49.2M AUM 60.1% 1-Year Est. Return

New Leaf Venture Partners's Q4 2017 Portfolio in Review

As of Q4 2017, New Leaf Venture Partners held 17 positions worth $214M, down 0.78% from $215M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

New Leaf Venture Partners withdrew a net $32.7M in Q4 2017, closing 1 position and reducing 5 holdings. Its most notable exit was Dimension Therapeutics, Inc, an estimated $12.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 98% a quarter earlier.

Against the trend, New Leaf Venture Partners opened a new position in ReShape Lifesciences Inc. Common Stock worth $3.85M.

  • New Leaf Venture Partners's largest Q4 2017 buy was ReShape Lifesciences Inc. Common Stock: 1,239 shares worth $3.85M.
  • New Leaf Venture Partners added most to ObsEva SA Ordinary Shares in Q4 2017, an estimated $6.4M increase.
  • New Leaf Venture Partners's biggest Q4 2017 reduction was iRhythm Holdings, cutting an estimated $19.6M.
  • New Leaf Venture Partners fully exited Dimension Therapeutics, Inc in Q4 2017, selling an estimated $12.4M.
  • New Leaf Venture Partners's ten largest holdings make up 94% of its $214M portfolio in Q4 2017.
  • New Leaf Venture Partners opened 1 new position and closed 1 in Q4 2017.
  • New Leaf Venture Partners's portfolio value fell 0.78% quarter-over-quarter to $214M.

Based on New Leaf Venture Partners's 13F filing for Q4 2017, filed 14 Feb 2018.